Advertisement

A New Level of Complexity: The Role of MicroRNAs in Cardiovascular Development.

20:32 EDT 18th May 2013 | BioPortfolio

Summary of "A New Level of Complexity: The Role of MicroRNAs in Cardiovascular Development."

The discovery of the regulatory role of noncoding RNAs, and micro (mi)RNAs in particular, has added a new layer of complexity to our understanding of cardiovascular development. miRNAs regulate and modulate various steps of cardiovascular morphogenesis, cell proliferation, differentiation, and phenotype modulation. miRNAs simultaneously regulate multiple targets, and many miRNAs can bind to the same target, allowing for a complex pattern of regulation of gene expression. miRNA families are continuously added during evolution paralleling the increased complexity of the cardiovascular system in vertebrates compared with invertebrates. Several lines of evidence suggest that the appearance of miRNAs is at least in part responsible for the formation of complex organ systems and stable regulatory mechanisms in vertebrates. We review the current understanding of miRNAs during cardiovascular development. Further progress in this area will help to decipher quantitative changes in gene expression that provide robustness to cellular phenotypes and regulatory options to diseases processes. miRNAs might also provide clues to better understand congenital heart defects, which are the most common birth defects in human newborns.

Affiliation

Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Ludwigstr 43, Bad Nauheim, Germany. Thomas.Braun@mpi-bn.mpg.de; E-mail Thomas.Boettger@mpi-bn.mpg.de.

Journal Details

This article was published in the following journal.

Name: Circulation research
ISSN: 1524-4571
Pages: 1000-13

Links

Medical and Biotech [MESH] Definitions

Developmental Disabilities

Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Cardiovascular Physiological Phenomena

Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.

Cardiovascular Physiological Processes

Biological actions and events that support the functions of the CARDIOVASCULAR SYSTEM.

Mads Domain Proteins

A superfamily of proteins that share a highly conserved MADS domain sequence motif. The term MADS refers to the first four members which were MCM1 PROTEIN; AGAMOUS 1 PROTEIN; DEFICIENS PROTEIN; and SERUM RESPONSE FACTOR. Many MADS domain proteins have been found in species from all eukaryotic kingdoms. They play an important role in development, especially in plants where they have an important role in flower development.

Cardiovascular Abnormalities

Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.

PubMed Articles [ 21112 Associated PubMed Articles listed on BioPortfolio]

microRNA profiling during mouse ventricular maturation A role for miR-27 modulating Mef2c expression.

Aims Non-coding RNA has been recently demonstrated to be novel mechanism for modulation of gene expression at the post-transcriptional level. The importance of microRNAs in the cardiovascular system i...

Pervasive roles of microRNAs in cardiovascular biology.

First recognized as regulators of development in worms and fruitflies, microRNAs are emerging as pivotal modulators of mammalian cardiovascular development and disease. Individual microRNAs modulate t...

Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease?

MicroRNAs are a class of small, noncoding RNAs encoded by the metazoan genome that regulate protein expression. A collection of studies point to vital roles for microRNAs in the onset and development...

MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets.

Hypertension is a complex, multifactorial disease, and its development is determined by a combination of genetic susceptibility and environmental factors. Several mechanisms have been implicated in th...

Antiviral effects of human microRNAs and conservation of their target sites.

MicroRNAs are small non-coding RNAs that modulate gene expression at post-transcriptional level, playing a crucial role in cell differentiation and development. Recently, some reports have shown that...

Clinical Trials [ 4118 Associated Clinical Trials listed on BioPortfolio]

Circulating microRNAs as Disease Markers in Pediatric Cancers

MicroRNAs are small molecules which have recently been discovered in cells. They are known to be responsible for the normal development of cells and when they are disrupted can contribute...

Uric Acid and Long-term Outcomes in Chronic Kidney Disease

Patients in the earlier stages of Chronic kidney disease (CKD) are at risk both for the development of end-stage renal disease (ESRD) (define by the requirement for dialysis or kidney tran...

Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women

To determine the role of dyslipidemia, markers of endothelial dysfunction genetic susceptibility, and dietary fat intake on the development of cardiovascular disease (CVD) complications in...

Antecedents of Hypertension: Role of Race and Stress

To determine the role of environmental stressors in the development of hypertension in Black and white school-age children from hypertensive families.

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

People with established cardiovascular disease need secondary prevention that addresses multiple risk factors. Complexity & cost confer particularly difficult barriers to uptake of treatme...

Search BioPortfolio: